Dihexa is a small peptide that has been developed to potently improve certain cognitive function of potential trauma-based brain disorders and neurodegenerative conditions through increased synaptogenesis
In the Phase 3 REDEFINE-1 trial, adding cagrilintide to semaglutide pushed average weight loss from 14.9% to 20.4%
This helps relieve symptoms of anaemia, including tiredness, fatigue, sore mouth and tongue, numbness and tingling in the arms and legs, memory loss and depression
While experiences vary, the most commonly discussed side effects include injection site irritation, headaches, nausea, fatigue, dizziness, and temporary digestive discomfort